Thus, we were the first to show that MSC transplantation in severe COVID-19 patients led to the elevation of plasma levels of pro-inflammatory cytokines such as IP-10, MIP-1α, G-CSF, and IL-10 without disease aggravation. The gene discussed is CCL3; the disease is COVID-19.